CAS: 936091-15-5
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | TG-46 REF: 54-BUP02548CAS: 936091-15-5 | ≥98% | 1,428.00 €~4,031.00 € | Mon 28 Apr 25 |
 | TG-46 REF: 7W-GW7223CAS: 936091-15-5 | - - - | 506.00 €~1,479.00 € | Tue 06 May 25 |
 | TG-46 REF: TM-T20743CAS: 936091-15-5 | 100% - 99.87% | 185.00 €~2,413.00 € | Tue 17 Jun 25 |
Ref: 54-BUP02548
| 25mg | 1,428.00 € | ||
| 50mg | 2,162.00 € | ||
| 100mg | 3,267.00 € | ||
| 200mg | 4,031.00 € |
Estimated delivery in United States, on Monday 28 Apr 2025
Ref: 7W-GW7223
| 1mg | 506.00 € | ||
| 5mg | 952.00 € | ||
| 10mg | 1,479.00 € |
Estimated delivery in United States, on Tuesday 6 May 2025
TG-46
CAS:936091-15-5
TG-46 (TG46) inhibits JAK2, FLT3, RET, JAK3 and can be used to study glaucoma.
Formula:
C26H34N6O3S
Purity:
100% - 99.87%
Color and Shape:
Solid
Molecular weight:
510.65
Ref: TM-T20743
| 1mg | 185.00 € | ||
| 5mg | 409.00 € | ||
| 10mg | 617.00 € | ||
| 25mg | 1,054.00 € | ||
| 50mg | 1,596.00 € | ||
| 100mg | 2,413.00 € |
Estimated delivery in United States, on Tuesday 17 Jun 2025
